Print this page    •   Back to Web version of article

International News
Funding Challenges for HIV Program in Zimbabwe

April 14, 2011

PlusNews IRIN examines the funding challenges Zimbabwe has faced with recently implementing WHO HIV treatment guidelines, which were introduced nearly one year ago. The newer drugs recommended in the WHO guidelines "are estimated to be one-and-a-half times more expensive than" older medicines. "With HIV/AIDS funding levels already worryingly low, AIDS activists have expressed concern that if these new expensive regimens are adopted, many people may fail to access treatment in the long run," the news service writes. Owen Mugurungi, national coordinator of the health ministry's AIDS and TB unit, acknowledged the new drugs are expensive, but said it could result in savings over the long-term. "When you do a cost-benefit analysis adopting the new drug regimen is recommendable ... our hope is that our development partners will assist us [in funding] the implementation of these new guidelines, we cannot do it alone," he said (4/12). Zimbabwe media reported on Wednesday that the Global Fund to Fight AIDS, Tuberculosis and Malaria turned down one of the country's grant applications. "Zimbabwe still has an option to apply for money through Round 11 of the fund due in December," the Zimbabwe Guardian reports (4/13).

Back to other news for April 2011

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. You can find this article online by typing this address into your Web browser:

General Disclaimer: is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.